“…24 The r56 antigen has been used successfully as a fused protein in passive hemagglutination assays 16 and an ELISA, 17 and in a truncated format in an ELISA and RFA. [13][14][15] In this report, we evaluated the ability of a new assay (KpKtGm r56 ELISA) to diagnose scrub typhus during an outbreak investigation utilizing sera collected from U.S. Marines training in Japan during two outbreaks of scrub typhus. 10,11 The recombinant protein antigens used in this assay were developed from the Karp, Kato, and Gilliam strains of O. tsutsugamushi.…”
Section: Discussionmentioning
confidence: 99%
“…The control line was purple for all tests conducted and was required for validity of the assays according to the manufacturer's instructions. 15 Western blot. The ELISA-and RFA-positive serum samples were assessed by Western blot analysis.…”
Section: Methodsmentioning
confidence: 99%
“…In this report, we describe the laboratory analysis of sera from 18 suspected cases and 46 controls from the two most recent outbreaks of scrub typhus at Camp Fuji using our standard trivalent (Karp, Kato, Gilliam) whole cell enzyme-linked immunosorbent assay (KpKtGm-wc ELISA), 12 and evaluating new assays using recombinant proteins: a cassette format rapid lateral flow assay (RCT) and an ELISA (Kp r56 ELISA) both using Kp recombinant 56-kD protein (r56), [13][14][15] and an ELISA and Western blot assay using r56 from the Karp, Kato, and Gilliam strains of O. tsutsugamushi (KpKtGm r56 ELISA and KpKtGm r56 Western blot, respectively). Recent studies with r56 from Karp in a passive hemagglutination assay, 16 ELISA, 13,17,18 and RCTs 14,15,18 have shown the utility of this new reagent when compared with previous assays that use whole cell antigens, including an ELISA, an indirect immunofluorescent antibody test, an indirect immunoperoxidase test , and a dot-blot immunoassay. The addition of r56 from other strains of O. tsutsugamushi, such as Gilliam and Boryong, has also proven effective.…”
“…24 The r56 antigen has been used successfully as a fused protein in passive hemagglutination assays 16 and an ELISA, 17 and in a truncated format in an ELISA and RFA. [13][14][15] In this report, we evaluated the ability of a new assay (KpKtGm r56 ELISA) to diagnose scrub typhus during an outbreak investigation utilizing sera collected from U.S. Marines training in Japan during two outbreaks of scrub typhus. 10,11 The recombinant protein antigens used in this assay were developed from the Karp, Kato, and Gilliam strains of O. tsutsugamushi.…”
Section: Discussionmentioning
confidence: 99%
“…The control line was purple for all tests conducted and was required for validity of the assays according to the manufacturer's instructions. 15 Western blot. The ELISA-and RFA-positive serum samples were assessed by Western blot analysis.…”
Section: Methodsmentioning
confidence: 99%
“…In this report, we describe the laboratory analysis of sera from 18 suspected cases and 46 controls from the two most recent outbreaks of scrub typhus at Camp Fuji using our standard trivalent (Karp, Kato, Gilliam) whole cell enzyme-linked immunosorbent assay (KpKtGm-wc ELISA), 12 and evaluating new assays using recombinant proteins: a cassette format rapid lateral flow assay (RCT) and an ELISA (Kp r56 ELISA) both using Kp recombinant 56-kD protein (r56), [13][14][15] and an ELISA and Western blot assay using r56 from the Karp, Kato, and Gilliam strains of O. tsutsugamushi (KpKtGm r56 ELISA and KpKtGm r56 Western blot, respectively). Recent studies with r56 from Karp in a passive hemagglutination assay, 16 ELISA, 13,17,18 and RCTs 14,15,18 have shown the utility of this new reagent when compared with previous assays that use whole cell antigens, including an ELISA, an indirect immunofluorescent antibody test, an indirect immunoperoxidase test , and a dot-blot immunoassay. The addition of r56 from other strains of O. tsutsugamushi, such as Gilliam and Boryong, has also proven effective.…”
“…Although home care tests such as dip-sticks and lateral flow immunochromatographic devices are widely available, they require the user to follow specific instructions and apply and blend reagents in a prescribed manner. This renders the tests practical only for relatively simple operations, and susceptible to both operator error and reagent contamination (Cardy and Allen 2004; Wilkinson et al 2003). To increase test robustness, it is desirable to minimize the user's involvement in performing process operations.…”
The building blocks for an inexpensive, disposable, luminescence-based microfluidic immunoassay cassette are described, and their integration in a point-of-care diagnostic system is demonstrated. Fluid motion in the cassette is driven by depressing finger-actuated pouches. All reagents needed for the immunoassay can be stored in the cassette in liquid form. Prior to use, the cassette consists of two separate parts. A top storage component contains pouches, sealed storage chambers, a metering chamber, and needle seats. The bottom processing component contains connection needles, a mixing chamber, and a detection chamber with immobilized proteins. Subsequent to sample introduction, the storage and processing components are mated. The needles form hydraulic connections between the two parts and, in some cases, close valves. The pouches are then actuated sequentially to induce flow of various reagents and facilitate process operations. The cassette is compatible with different detection modalities. Both a cassette with immunochromatographic-based detection and a cassette with microbead-based detection were constructed and evaluated. The immunochromatographic cassette was used to detect antibodies to HIV in saliva samples. The bead-based cassette was used to detect the proinflammatory chemokine IL-8. The experimental data demonstrates good repeatability and reasonable sensitivity.
“…Thus, a sensitive, rapid lateral flow assay that identifies Orientia tsutsugamushi-specific IgG/IgM antibodies is being developed. 51 Patients typically have a normal white blood cell count, with lymphocytosis in the majority of cases. About half of the patients have elevated aspartate aminotransferase and 20% have proteinuria.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.